Phase II Randomized Study Of Rituximab, Methotrexate, Procarbazine, Vincristine, And Cytarabine With And Without Low-Dose Whole-Brain Radiotherapy For
Posted Date: May 15, 2019
- Investigator: Jordan Kharofa
- Type of Study: Drug
This study is to determine the effects, good and/or bad, of the combination of low-dose whole brain radiation plus chemotherapy compared with chemotherapy alone, on patients and their tumors. The study will last 6-7 months
Criteria:
Eligible Patients Must Have Primary Central Nervous System Lymphoma (Pcnsl)
Keywords:
Brain Tumor, Central Nervous Syst, Lymphoma, Phase Ii, Rtog 1114
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu